Global /China /Healthcare /Biotechnology /688317

Shanghai ZJ Bio-Tech Co., Ltd.

688317

• SSE: 688317 • Delayed

19.50CNY -2%

2.88 USD

As of 17 June 2026, Shanghai ZJ Bio-Tech Co., Ltd. has a market cap of $512.27M USD, ranking #15023 globally and #4684 in China. It ranks #1336 in the Healthcare sector, and #252 in the Biotechnology industry.

Global Rank

15023

Country Rank

4684

Sector Rank

1336

Industry Rank

252

Key Stats

Market Cap

$512.27MUSD

3.46B CNY

Enterprise Value

$127.08MUSD

859.98M CNY

Revenue (TTM)

$18.47MUSD

124.82M CNY

EBITDA (TTM)

-$4.67MUSD

-31.59M CNY

Net Income (TTM)

-$5.08MUSD

-34.3M CNY

EBITDA Margin

-25%

Profit Margin

-27%

PS Ratio

27.7

PB Ratio

1.0

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Junbin Shao open_in_new

Employees

275

Founded

2005

Website

liferiver.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2%	-2.7%	1.4%	-15%	-14%	-3.2%	21%	-28%	-73%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688317 上海之江生物科技股份有限公司 Class A ISIN: CNE100005DB6 Shares Out.: Shares Outstanding: 174.767M¹ Shares Float: 174.759M² TV: TradingView: SSE: 688317 SA: Stock Analysis: SHA: 688317 YF: Yahoo Finance: 688317.SS GF: Google Finance: SHA: 688317 BA: Barron's: 688317 MS: Morningstar: XSHG: 688317	19.50 CNY	TV: TradingView: SSE: 688317 SA: Stock Analysis: SHA: 688317 YF: Yahoo Finance: 688317.SS GF: Google Finance: SHA: 688317 BA: Barron's: 688317 MS: Morningstar: XSHG: 688317

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shanghai ZJ Bio-Tech Co., Ltd.

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.45B 136.71B HKD 3K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 2K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.03B 54.23B CNY 1K%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.35B 49.69B CNY 1K%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 1K%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.74B 45.52B CNY 1K%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 36K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 31K%	19.0	United States
argenx SE EBR: ARGX	$47.99B 41.39B EUR 9K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$45.17B 68.19T KRW 9K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.62B 60.27B AUD 8K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.46B 33.71B CHF 8K%	37.2	Switzerland

chevron_leftBack